Combination Treatment of Human Pancreatic Cancer Xenograft Models with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib and Oncolytic Herpes Simplex Virus HF10

Author： Yamamura Kazuo   Kasuya Hideki   Sahin Tevfik   Tan Gewen   Hotta Yoshihiro   Tsurumaru Naoko   Fukuda Saori   Kanda Mitsuro   Kobayashi Daisuke   Tanaka Chie   Yamada Suguru   Nakayama Goro   Fujii Tsutomu   Sugimoto Hiroyuki   Koike Masahiko   Nomoto Shuji   Fujiwara Michitaka   Tanaka Maki   Kodera Yasuhiro  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.21, Iss.2, 2014-02, pp. : 691-698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models

By Chen Jianping   Smith Melissa   Kolinsky Kenneth   Adames Violeta   Mehta Nila   Fritzky Luke   Rashed Mohammad   Wheeldon Eric   Linn Michael   Higgins Brian  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 651-659

Springer Publishing Company

Access to resources Recommend Favorite

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

By Carrera S.   Buque A.   Azkona E.   Aresti U.   Calvo B.   Sancho A.   Arruti M.   Nuño M.   Rubio I.   Lobera A.   Lopez C.   Vivanco G.  

Clinical and Translational Oncology, Vol. 16, Iss. 4, 2014-04 ,pp. : 339-350

Springer Publishing Company

Access to resources Recommend Favorite

Pilot Study of Oncolytic Viral Therapy Using Mutant Herpes Simplex Virus (HF10) Against Recurrent Metastatic Breast Cancer

By Kimata Hideto   Imai Tsuneo   Kikumori Toyone   Teshigahara Osamu   Nagasaka Tetsuro   Goshima Fumi   Nishiyama Yukihiro   Nakao Akimasa  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1078-1084

Springer Publishing Company

Access to resources Recommend Favorite

Oncolytic herpes simplex virus treatment of metastatic breast cancer

By          

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 757-763

Spandidos Publications

Access to resources Recommend Favorite

Effects of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in EGFR-mutated non-small cell lung cancer

By        

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 2066-2072

Spandidos Publications

Access to resources Recommend Favorite